Comparison of neurocognitive changes among newly diagnosed tuberculosis patients with and without dysglycaemia

BMC Psychiatry

Table 2 Summary of Independent t-test for 2HPP and neuropsychological measures among newly diagnosed smear positive tuberculosis patients at the Chest Clinic of the Korle-Bu Teaching hospital in Accra, Ghana, 2017

	2HPP	n	M	SD	t	df	p
Cognitive Failures (CFQ)	Normal	93	19.23	13.20	1.25	152	.202
Cognitive Failures (CFQ)	Abnormal	61	16.61	11.86	1.25	152	.202
Somatisation	Normal	92	1.27	.81	−.38	152	.704
Somatisation	Abnormal	62	1.32	.77	−.38	152	.704
Anxiety	Normal	92	.55	.66	1.53	152	.106
Anxiety	Abnormal	62	.41	.48	1.53	152	.106
Depression	Normal	91	.52	.59	.68	151	.477
Depression	Abnormal	62	.46	.45	.68	151	.477
Phobic Anxiety	Normal	92	.38	.60	2.03	149.7	.045
Phobic Anxiety	Abnormal	62	.23	.36	2.03	149.7	.045
Perceived Psychological Distress (BSI-GSI)	Normal	92	.65	.47	1.21	151.8	.229
Perceived Psychological Distress (BSI-GSI)	Abnormal	62	.58	.30	1.21	151.8	.229
Total Free Recall	Normal	70	20.13	5.83	.87	105	.353
Total Free Recall	Abnormal	37	19.16	4.65	.87	105	.353
Short Delay Free Recall	Normal	70	5.47	1.96	1.61	105	.120
Short Delay Free Recall	Abnormal	37	2.12	1.61	1.61	105	.120
Long Delay Free Recall	Normal	68	4.76	2.02	1.03	102	.307
Long Delay Free Recall	Abnormal	36	4.33	2.04	1.03	102	.307
Cognitive Impairment (MOCA)	Normal	84	17.26	5.98	2.10	132	.037
Cognitive Impairment (MOCA)	Abnormal	50	15.04	5.83	2.10	132	.037
Quality of Life	Normal	93	7.20	1.90	1.30	153	.197
Quality of Life	Abnormal	62	6.82	1.59	1.30	153	.197

p < .05 (2-tailed), Note: M Mean, SD Standard deviation, df Degree of freedom, BSI Brief Symptom Inventory, GSI Global severity index, MOCA Montreal Cognitive Assessment, Abnormal Dysglyacaemia

ISSN: 1471-244X